Archive for April, 2011

Leishmania as a re-emerging pathogen

Wednesday, April 13th, 2011

Microbiology Today Leishmaniasis has been recognized since ancient times and, with at least 50,000 deaths a year due to this parasitic infection, it is certainly of current importance. In this article in Microbiology Today (pdf) Owain Millington asks is there any evidence to suggest that it can be considered as a re-emerging disease?

Leishmaniasis has been recognized for several hundred years, with descriptions of cutaneous lesions as early as the 7th century BC. However, it wasn’t until early in the 20th century that Major William Leishman and Charles Donovan independently identified a parasite as the causative agent of ‘kala-azar’. Writing in 1904, Leishman suggested that the identification of Leishmania would ‘help us in clearing up the rest of the life history of the parasite, and put us on the track to what should be our ultimate goal – the prevention and, if possible, the stamping out of the disease’. Yet, despite over a hundred years of intensive research into understanding both this protozoan parasite and the host biology, cases of leishmaniasis in the 21st century are on the increase, with widespread drug resistance and no effective vaccine.

 

 

Read more

Human metapneumovirus in wild mountain gorillas

Monday, April 11th, 2011

Mountain gorilla The world’s remaining 786 mountain gorillas (Gorilla beringei beringei) live in 2 parks in Rwanda, Uganda, and the Democratic Republic of the Congo. An ecotourism industry for viewing human-habituated mountain gorillas in the wild is thriving in all 3 countries. Mountain gorilla tourism helps ensure the sustainability of the species by generating much-needed revenue and increasing global awareness of the precarious status of this species in the wild. Tourism, however, also poses a risk for disease transmission from humans to the gorillas.

Habitat encroachment and poaching are threats to wildlife survival, particularly in the developing world. Mountain gorillas face an additional threat from infectious diseases. Second only to trauma, infectious diseases, primarily respiratory, account for 20% of sudden deaths. The close genetic relatedness of mountain gorillas and humans has led to concerns about the potential interspecies transmission of infectious agents. Although most surveillance efforts focus on risk for humans, mountain gorillas are immunologically naive and susceptible to infection with human pathogens. The parks in which mountain gorillas live are surrounded by the densest human populations in continental Africa. In addition, research and gorilla ecotourism brings thousands of persons from the local communities and from around the world into direct and indirect contact with the gorillas. The frequency and closeness of contact is particularly pronounced in Virunga National Park, where 75% of mountain gorillas are habituated to the presence of humans.

To minimize the threat of disease transmission, the Rwandan, Ugandan, and Congolese governments restrict tourist numbers and proximity, and the Congolese wildlife authority mandates that masks be worn by persons visiting gorillas. Nonetheless, the frequency and severity of respiratory disease outbreaks among mountain gorillas in the Virunga Massif have recently increased. From May through August 2008, sequential respiratory outbreaks occurred in 4 groups of mountain gorillas accustomed to tourism in Rwanda. Between June 28 and August 6, 2009, a fifth outbreak occurred in 1 of these groups, Hirwa. This paper describes the Hirwa outbreak. Respiratory outbreaks were defined as more than one third of animals in a group exhibiting signs of respiratory disease (coughing, oculonasal discharge, and/or lethargy).

Human metapneumovirus infection in wild mountain gorillas, Rwanda. Emerg Infect Dis. Apr 2011 doi: 10.3201/eid1704.100883
The genetic relatedness of mountain gorillas and humans has led to concerns about interspecies transmission of infectious agents. Human-to-gorilla transmission may explain human metapneumovirus in two wild mountain gorillas that died during a respiratory disease outbreak in Rwanda in 2009. Surveillance is needed to ensure survival of these critically endangered animals.

Related:

Viral Encephalomyelitis

Friday, April 8th, 2011

Viral Encephalomyelitis Viral encephalomyelitis is an important cause of morbidity and mortality worldwide, and many encephalitic viruses are emerging and re-emerging due to changes in virulence, spread to new geographic regions, and adaptation to new hosts and vectors. The term encephalomyelitis refers to inflammation in the brain and spinal cord that results from the immune response to virus infection. In humans, the viruses most commonly identified as causes of viral encephalomyelitis are herpesviruses and RNA viruses in the enterovirus (e.g., polio, enterovirus 71), rhabdovirus (e.g., rabies), alphavirus (e.g., eastern equine, Venezuelan equine, and western equine encephalitis), flavivirus (e.g., West Nile, Japanese encephalitis, Murray Valley, and tick-borne encephalitis), and bunyavirus (e.g., La Crosse) families. Other virus families with members that can cause acute encephalitis are the paramyxoviruses (e.g., Nipah, Hendra) and arenaviruses (e.g., lymphocytic choriomeningitis, Junin). However, this is certainly not a complete list, because for most cases of human viral encephalitis the etiologic agent is not identified, even when heroic attempts are made.

The primary target cells for most encephalitic viruses are neurons, although a few viruses attack cerebrovascular endothelial cells to cause ischemia and stroke or glial cells to cause demyelination, encephalopathy, or dementia. Widespread infection of neurons may occur or viruses may display preferences for particular types of neurons in specific locations in the central nervous system (CNS). For instance, herpes simplex virus (HSV) type 1 often infects neurons in the hippocampus to cause behavioral changes, while poliovirus preferentially infects motor neurons in the brainstem and spinal cord to cause paralysis and Japanese encephalitis virus infects basal ganglia neurons to cause symptoms similar to those of Parkinson’s disease. Because infections with encephalitic viruses are initiated outside the CNS (e.g., with an insect bite, skin, respiratory, or gastrointestinal infection), innate and adaptive immune responses are usually mounted rapidly enough to prevent virus entry into the CNS. Therefore, most viruses that can cause encephalitis more often cause asymptomatic infection or a febrile illness without neurologic disease, and encephalomyelitis is an uncommon complication of infection.

Viral Encephalomyelitis. 2011 PLoS Pathog 7(3): e1002004. doi:10.1371/journal.ppat.1002004
Encephalomyelitis resulting from virus infection of neurons is a disease that can be fatal or result in permanent disability due to irreversible damage of infected neurons. The immune response to infection can enhance neuronal damage or can control virus replication by noncytolytic mechanisms and thus determine outcome. However, noncytolytic virus clearance results in persistence of viral nucleic acid in the CNS and thus establishes a need for long-term local immune responses to prevent reactivation of infection and progressive disease. Understanding these mechanisms is necessary for development of strategies for treating and preventing neurologic disease due to viral encephalomyelitis.

WHO World Health Day

Thursday, April 7th, 2011

World Health Day “We live in an era in which we depend on antibiotics, and other antimicrobial medicines to treat conditions that decades ago, or even a few years ago in the case of HIV/AIDS, would have proved fatal. When antimicrobial resistance – also known as drug resistance – occurs, it renders these medicines ineffective. For World Health Day 2011, WHO will be calling for intensified global commitment to safeguard these medicines for future generations. Antimicrobial resistance – the theme of World Health Day 2011, 7 April 2011 – and its global spread, threatens the continued effectiveness of many medicines used today to treat infectious diseases. For World Health Day 2011, WHO will call on governments and stakeholders to implement the policies and practices needed to prevent and counter the emergence of highly resistant microorganisms.”

via WHO | World Health Day – 7 April 2011

Emerging fungal pathogens

Wednesday, April 6th, 2011

Microbiology Today As the number of immunocompromised individuals grows, fungal pathogens are becoming ever more important. In this article in Microbiology Today (pdf) Ken Haynes discusses how functional genomics technologies are helping to combat these less than well known eukaryotic adversaries:

The late 20th and early 21st centuries have seen the emergence (HIV), re-emergence (TB) and progression (malaria) of infectious disease around the world. The antibiotic age seemed to have rid us, the developed world at least, of the massive impact wrought by devastating infectious diseases. However, the war has not been won. Microbial pathogens have fought back, with extraordinary resourcefulness. Antibiotic resistance has given rise to populations of bacteria that are almost untreatable; vancomycin-resistant Staphylococcus aureus is a prime example. In addition, successful antibiotic therapies, combined paradoxically with advances in medical treatments, especially in the areas of transplantation and chemotherapy, have resulted in the emergence of a large group of immunocompromised patients that are now at serious risk of invasive, life-threatening disease from a group of fungi. These organisms are perhaps less well known than their bacterial and viral counterparts, but are nonetheless devastating for that.

 

Read more

Still blaming the badgers?

Monday, April 4th, 2011

Save our badgers I’m trying to persuade a student to do my final year project next year on badger culling and bovine tuberculosis:

Bovine tuberculosis (bTB) remains an important public health concern worldwide as a result of deficiencies in preventing and/or controlling measures targeting the spread of its causative agent Mycobacterium bovis. While the risk posed by M. bovis to human health is low in most developed countries, the main causes of concern related to M. bovis in industrialized countries are epizootics in domesticated and wild mammal populations. Infection with M. bovis remains a significant livestock zoonosis in the European Union where some member states experience a reemergence of the disease despite significant historical efforts to implement eradication plans. In Great Britain, the disease was eliminated from most cattle herds by 1960, with the exception of infection hotspots in southwest England, after the implementation of a herd testing and slaughter policy. However, efforts to completely eradicate bTB in Great Britain have been hampered by the maintenance of M. bovis in wildlife host populations, acting as reservoirs of infection, in particular badgers (Meles meles). Since 1979, incidence in British cattle has increased and the infection has become more geographically widespread. Over 7 million cattle were tested for bovine bTB in 2009 and one in ten herds experienced bTB-related movement restrictions during the year as a result of at least one member of the herd failing the tuberculin skin test or showing lesions consistent with bTB during the slaughterhouse inspection – an event known as a “herd breakdown”.

Local Cattle and Badger Populations Affect the Risk of Confirmed Tuberculosis in British Cattle Herds. 2011 PLoS ONE 6(3): e18058. doi:10.1371/journal.pone.0018058
Background: The control of bovine tuberculosis (bTB) remains a priority on the public health agenda in Great Britain, after launching in 1998 the Randomised Badger Culling Trial (RBCT) to evaluate the effectiveness of badger (Meles meles) culling as a control strategy. Our study complements previous analyses of the RBCT data (focusing on treatment effects) by presenting analyses of herd-level risks factors associated with the probability of a confirmed bTB breakdown in herds within each treatment: repeated widespread proactive culling, localized reactive culling and no culling (survey-only).
Methodology/Principal Findings: New cases of bTB breakdowns were monitored inside the RBCT areas from the end of the first proactive badger cull to one year after the last proactive cull. The risk of a herd bTB breakdown was modeled using logistic regression and proportional hazard models adjusting for local farm-level risk factors. Inside survey-only and reactive areas, increased numbers of active badger setts and cattle herds within 1500 m of a farm were associated with an increased bTB risk. Inside proactive areas, the number of M. bovis positive badgers initially culled within 1500 m of a farm was the strongest predictor of the risk of a confirmed bTB breakdown.
Conclusions/Significance: The use of herd-based models provide insights into how local cattle and badger populations affect the bTB breakdown risks of individual cattle herds in the absence of and in the presence of badger culling. These measures of local bTB risks could be integrated into a risk-based herd testing programme to improve the targeting of interventions aimed at reducing the risks of bTB transmission.

Related:

Fabulous Measles Timeline

Sunday, April 3rd, 2011

From History of Vaccines:

Measles timeline

Covering all the bases with next-generation sequencing

Friday, April 1st, 2011

Covering all the bases with next-generation sequencing In this article in Microbiology Today Ed Feil describes how we must brace ourselves for the next wave of data as new sequencing techniques become available to determine and compare many sequences at once. The enormous amount of data soon to be generated will bring exciting new insights into how micro-organisms within communities evolve and interact:

Regardless of the species in question, announcements of completed genome sequencing projects in the mainstream media almost invariably make reference to ‘cracking a code’ or ‘deciphering a genetic blueprint’. For bacteria, these over-used analogies spectacularly fail to give a true sense of the fluidity of genome evolution. The doe-eyed assumption in the mid-1990s that a single genome sequence can safely be considered as a prescriptive ‘solution’ for a given bacterial species has been dramatically falsified. By the late 1990s, multiple genome sequences for Escherichia coli revealed extensive differences in gene content between strains, and it rapidly became clear that, for many taxa, an individual genome is most usefully considered as one of many possible combinations of genes drawn from a vast pool known as the pangenome. When faced with such a maelstrom, our natural inclination (as good cladists) is to try and tidy it up, and catalogue strains into pockets of relatedness. Fortunately, phylogenetic analyses are possible, even for very variable species like E. coli, because one can readily identify genes which are universally present in all strains. These essential ‘core’ genes can be thought of as representing the operating system of a given species. In contrast, the specialist software is provided by ‘non-core’ or ‘accessory’ genes which are variably present or absent, are commonly acquired by horizontal transfer, and tend to be restricted to hypervariable regions called genomic islands. These two sets of genes present a fundamental duality in bacterial genomics. Whilst core genes can satisfy our requirements for molecular phylogeny (i.e. what a strain is), accessory genes often play a significant role in adaptation and phenotypic differences (i.e. what a strain does). Conflicts between these two can go a long way to explaining the mystery behind the muddle that is bacterial systematics.

Read more